دورية أكاديمية

Biosynthesis and function of chondroitin sulfate.

التفاصيل البيبلوغرافية
العنوان: Biosynthesis and function of chondroitin sulfate.
المؤلفون: Mikami T; Department of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan., Kitagawa H
المصدر: Biochimica et biophysica acta [Biochim Biophys Acta] 2013 Oct; Vol. 1830 (10), pp. 4719-33. Date of Electronic Publication: 2013 Jun 14.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Pub. Co Country of Publication: Netherlands NLM ID: 0217513 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-3002 (Print) Linking ISSN: 00063002 NLM ISO Abbreviation: Biochim Biophys Acta Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier Pub. Co.
مواضيع طبية MeSH: Chondroitin Sulfates/*biosynthesis , Chondroitin Sulfates/*physiology, Enzymes/metabolism
مستخلص: Background: Chondroitin sulfate proteoglycans (CSPGs) are principal pericellular and extracellular components that form regulatory milieu involving numerous biological and pathophysiological phenomena. Diverse functions of CSPGs can be mainly attributed to structural variability of their polysaccharide moieties, chondroitin sulfate glycosaminoglycans (CS-GAG). Comprehensive understanding of the regulatory mechanisms for CS biosynthesis and its catabolic processes is required in order to understand those functions.
Scope of Review: Here, we focus on recent advances in the study of enzymatic regulatory pathways for CS biosynthesis including successive modification/degradation, distinct CS functions, and disease phenotypes that have been revealed by perturbation of the respective enzymes in vitro and in vivo.
Major Conclusions: Fine-tuned machineries for CS production/degradation are crucial for the functional expression of CS chains in developmental and pathophysiological processes.
General Significance: Control of enzymes responsible for CS biosynthesis/catabolism is a potential target for therapeutic intervention for the CS-associated disorders.
(Copyright © 2013 Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: Biosynthesis/catabolism; C4ST; C6ST; CS; ChABC; ChGn; ChPF; ChSy; Chn; Chondroitin sulfate; D4ST; DS; DS-epi; EXT; EXT-like; EXTL; FAM; GAG; Gal; GalNAc; GalNAc 4-sulfate 6-O-sulfotransferase; GalNAc transferase; GalNAc4S-6ST; GalNAcT; GalT-I; GalT-II; GlcA; GlcA C-5 epimerase (DS epimerase); GlcA transferase-II; GlcAT-I; GlcAT-II; GlcNAc; GlcNAc transferase; GlcNAcT; Glycosaminoglycan; Glycosyltransferase; HA; HNK-1; HS; HSV; HYAL; N-acetylgalactosamine; N-acetylglucosamine; PG; Proteoglycan; Ser; Sulfotransferase; TM; UST; Xyl; XylT; chondroitin; chondroitin 4-O-sulfotransferase; chondroitin 6-O-sulfotransferase; chondroitin GalNAc transferase; chondroitin polymerizing factor; chondroitin sulfate; chondroitin synthase; chondroitinase ABC; dermatan 4-O-sulfotransferase; dermatan sulfate; exostosin; family with sequence similarity; galactose; glucuronic acid; glycosaminoglycan; heparan sulfate; herpes simplex virus; human natural killer-1; hyaluronan; mammalian hyaluronidase; proteoglycan; serine; thrombomodulin; uronyl 2-O-sulfotransferase; xylose; xylosyltransferase; β1,3-galactosyltransferase-II; β1,3-glucuronyltransferase-I; β1,4-galactosyltransferase-I
المشرفين على المادة: 0 (Enzymes)
9007-28-7 (Chondroitin Sulfates)
تواريخ الأحداث: Date Created: 20130619 Date Completed: 20131101 Latest Revision: 20220318
رمز التحديث: 20221213
DOI: 10.1016/j.bbagen.2013.06.006
PMID: 23774590
قاعدة البيانات: MEDLINE
الوصف
تدمد:0006-3002
DOI:10.1016/j.bbagen.2013.06.006